Drew W. Rasco, MD
Associate Director, Clinical Research
Dr. Drew W. Rasco is the Associate Director of Clinical Research at START. He is board-certified in both Hematology and Oncology. He completed medical school in 2003 at the University of Texas Health Sciences Center in San Antonio, TX. He completed his residency in Internal Medicine at the Emory University School of Medicine in Atlanta, GA. He followed this with fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center in Dallas, TX.
Dr. Rasco’s major interest is in the development of new anticancer agents, with a special interest in malignancies of the gastrointestinal tract and lungs.
Dr. Rasco is a member of the American Society of Clinical Oncology (ASCO). He was a recipient of the Resident Achievement Award from Emory University. He and his partners at START have led an extensive number of phase I clinical trials, including those that eventually led to the FDA approvals of pembrolizumab, cemiplimab, abemaciclib, copanlisib, and others. Most recently, he served as the principal investigator for the combination of lenvatinib and pembrolizumab, which received FDA approval for endometrial (uterine) cancer in 2019.
Areas of Expertise
Pancreas
GI
In The Press
Publications
By:
- Amita Patnaik, MD, FRCPC, Drew W. Rasco, MD, Kyriakos P. Papadopoulos, MD, Lon Smith, MD, M. Beeram, MD
Journal: Clin Cancer Res.
Published Date: May 14, 2015
By:
- Amita Patnaik, MD, FRCPC, Drew W. Rasco, MD, Kyriakos P. Papadopoulos, MD, Lon Smith, MD, M. Beeram, MD
Journal: Clin Cancer Res.
Published Date: May 14, 2015
By:
- Amita Patnaik, MD, FRCPC, Drew W. Rasco, MD, Kyriakos P. Papadopoulos, MD
Journal: Cancer Discovery
Published Date: May 23, 2016
By:
- Amita Patnaik, MD, FRCPC, Drew W. Rasco, MD, Kyriakos P. Papadopoulos, MD, Muralidhar Beeram, MD, MBBS, Nehal Lakhani, MD, PhD, Sreenivasa R. Chandana, MD
Journal: Journal of Clinical Oncology
Published Date: April 20, 2019
By:
- Amita Patnaik, MD, FRCPC, Drew W. Rasco, MD
Journal: Cancer Chemother Pharmacol.
Published Date: November 8, 2021
By:
- Drew W. Rasco, MD, Nehal Lakhani, MD, PhD
Journal: Clinical Cancer Research
Published Date: February 1, 2024